Literature DB >> 27070482

Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension.

Stefan Guth1, Christoph B Wiedenroth1, Thorsten Kramm1, Eckhard Mayer1.   

Abstract

Pulmonary endarterectomy is a curative treatment option for patients with chronic thromboembolic pulmonary hypertension (CTEPH). There is a growing body of evidence suggesting that not only patients with CTEPH but also patients with pulmonary arterial obstructions and mean pulmonary artery pressures < 25 mmHg should be offered surgery. In this review, the recent literature regarding pathophysiology, diagnostic methods, decision making by an expert CTEPH team, and surgical techniques will be summarized. Novel alternative treatment options for inoperable CTEPH patients will be discussed, i.e. targeted medical therapy and balloon pulmonary angioplasty. For the future the major task will be to define a clear selection process for the optimal treatment of the individual CTEPH patient.

Entities:  

Keywords:  BPA; CTEPH; PEA; Pulmonary endarterectomy; balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; pulmonary embolism; pulmonary hypertension

Mesh:

Year:  2016        PMID: 27070482     DOI: 10.1080/17476348.2016.1176915

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  7 in total

Review 1.  Chronic Thromboembolic Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis.

Authors:  Humna Abid Memon; C Huie Lin; Ashrith Guha
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

2.  Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension at a Single Center in Taiwan.

Authors:  Yu-Jhou Chen; Chien-Te Ho; Feng-Chun Tsai; Chia-Pin Lin; Lung-An Hsu; Chun-Li Wang; Kuang-Tso Lee; Wan-Jing Ho
Journal:  Acta Cardiol Sin       Date:  2019-03       Impact factor: 2.672

3.  Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry.

Authors:  Abdullah M Aldalaan; Sarfraz A Saleemi; Ihab Weheba; Abeer Abdelsayed; Pekka Hämmäinen; Maha M Aleid; Fatima Alzubi; Hamdeia Zaytoun; Nadeen Alharbi
Journal:  ERJ Open Res       Date:  2020-05-11

4.  Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.

Authors:  Steffen D Kriechbaum; Lillith Scherwitz; Christoph B Wiedenroth; Felix Rudolph; Jan-Sebastian Wolter; Moritz Haas; Ulrich Fischer-Rasokat; Andreas Rolf; Christian W Hamm; Eckhard Mayer; Stefan Guth; Till Keller; Stavros V Konstantinides; Mareike Lankeit; Christoph Liebetrau
Journal:  ERJ Open Res       Date:  2020-11-02

5.  Neuroprotective effects of dynamic bubble trap use in patients undergoing pulmonary endarterectomy: a two-arm randomized controlled trial.

Authors:  Stefan Guth; Martin Juenemann; Jasmin El Shazly; Tibo Gerriets; Juergen Hennig; Marius Butz; Sabrina Kastaun; Christoph B Wiedenroth; Markus Schoenburg; Marc Wollenschlaeger; Georg Bachmann
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

6.  Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy - a cardiac magnetic resonance imaging cohort study.

Authors:  Steffen D Kriechbaum; Julia M Vietheer; Christoph B Wiedenroth; Felix Rudolph; Marta Barde; Jan-Sebastian Wolter; Moritz Haas; Ulrich Fischer-Rasokat; Maren Weferling; Andreas Rolf; Christian W Hamm; Eckhard Mayer; Stefan Guth; Till Keller; Fritz C Roller; Christoph Liebetrau
Journal:  Pulm Circ       Date:  2021-12-10       Impact factor: 3.017

7.  Preoperative platelet count, preoperative hemoglobin concentration and deep hypothermic circulatory arrest duration are risk factors for acute kidney injury after pulmonary endarterectomy: a retrospective cohort study.

Authors:  Congya Zhang; Guyan Wang; Hui Zhou; Guiyu Lei; Lijing Yang; Zhongrong Fang; Sheng Shi; Jun Li; Zhiyan Han; Yunhu Song; Sheng Liu
Journal:  J Cardiothorac Surg       Date:  2019-12-30       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.